A live, programmable microbiota therapeutic disables virulence in gut pathogens

1. Gencay, Y. E. et al. Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice. Nat. Biotechnol. 42, 265–274 (2024). This study reports the development and evaluation of engineered phages armed with CRISPR–Cas systems that selectively reduce pathogenic E. coli.

   CAS  PubMed  Google Scholar 

2. Ronda, C., Chen, S. P., Cabral, V., Yaung, S. J. & Wang, H. H. Metagenomic engineering of the mammalian gut microbiome in situ. Nat. Methods 16, 167–170 (2019). This paper describes the initial demonstration of microbiota engineering directly in the gut.

   CAS  PubMed  PubMed Central  Google Scholar 

3. Vo, P. L. H. et al. CRISPR RNA-guided integrases for high-efficiency, multiplexed bacterial genome engineering. Nat. Biotechnol. 39, 480–489 (2021). This paper describes RNA-guided transposases that allow high-efficiency and multiplexed genome editing in bacteria.

   CAS  PubMed  Google Scholar 

4. Ruano-Gallego, D. et al. A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa. PLoS Pathog. 15, e1008031 (2019). This study identifies and characterizes a nanobody capable of inhibiting attachment of enterohaemorrhagic E. coli to human intestinal tissues.

   CAS  PubMed  PubMed Central  Google Scholar 

5. Lentsch, V. et al. Vaccine-enhanced competition permits rational bacterial strain replacement in the gut. Science 388, 74–81 (2025). This study used oral vaccination with engineered competitor E. coli strains to trigger immune-mediated selective replacement of pathogenic E. coli in the gut.

   CAS  PubMed  PubMed Central  Google Scholar 

Download references

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Ronda, C. et al. Precise virulence inactivation using a CRISPR-associated transposase for combating Enterobacteriaceae gut pathogens. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-025-01453-1 (2025).